Market Research Logo

Myriad Genetics Inc (MYGN) - Product Pipeline Analysis, 2018 Update

Summary

Myriad Genetics Inc (Myriad) is a specialty molecular diagnostic company, which discovers and commercializes molecular diagnostic tests, personalized medicine and services for major diseases. The company’s product portfolio includes molecular diagnostic testing products that analyze genes, their expression levels and corresponding proteins to assess a person risk for developing disease later in life, accurately diagnose disease and determine a patient’s likelihood of responding to a particular drug. It also provides an array of pharmaceutical and clinical services. Myriad markets its products through its sales force in Europe and Canada and through distributor agreements in Latin American, Middle Eastern, Asian and African countries. The company has operations in the US, Spain, France, Switzerland, the UK, Canada, the Netherlands and Italy. Myriad is headquartered in Salt Lake City, Utah, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Myriad Genetics Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Myriad Genetics Inc Company Overview
Myriad Genetics Inc Company Snapshot
Myriad Genetics Inc Pipeline Products and Ongoing Clinical Trials Overview
Myriad Genetics Inc – Pipeline Analysis Overview
Business Description
Myriad Genetics Inc - Key Facts
Myriad Genetics Inc - Major Products and Services
Myriad Genetics Inc Pipeline Products by Development Stage
Myriad Genetics Inc Ongoing Clinical Trials by Trial Status
Myriad Genetics Inc Pipeline Products Overview
BRACAnalysis CDx - Talazoparib
BRACAnalysis CDx - Talazoparib Product Overview
ChemoPredict Test
ChemoPredict Test Product Overview
Diagnostic Assay - Lung Cancer
Diagnostic Assay - Lung Cancer Product Overview
Diagnostic Assay - HER2+/TNBC-Breast Cancer
Diagnostic Assay - HER2+/TNBC-Breast Cancer Product Overview
Diagnostic Assay - Juvenile Idiopathic Rheumatoid Arthritis
Diagnostic Assay - Juvenile Idiopathic Rheumatoid Arthritis Product Overview
Diagnostic Assay - Melanoma
Diagnostic Assay - Melanoma Product Overview
Diagnostic Assay - Prostate Cancer
Diagnostic Assay - Prostate Cancer Product Overview
Diagnostic Test - Alzheimer's Disease
Diagnostic Test - Alzheimer's Disease Product Overview
Diagnostic Test - Colon Cancer
Diagnostic Test - Colon Cancer Product Overview
Diagnostic Test - Kidney Damage
Diagnostic Test - Kidney Damage Product Overview
GeneSight Test - MDD
GeneSight Test - MDD Product Overview
GeneSight Test - MDD Clinical Trial
Genetic Risk Score Test
Genetic Risk Score Test Product Overview
Genetic Risk Score Test Clinical Trial
HRD Companion Diagnostic Test - Breast Cancer
HRD Companion Diagnostic Test - Breast Cancer Product Overview
Kidney Transplant Rejection Test
Kidney Transplant Rejection Test Product Overview
Multi-Biomarker Test - Ankylosing Spondylitis
Multi-Biomarker Test - Ankylosing Spondylitis Product Overview
Multi-Biomarker Test - Autoimmune Diseases
Multi-Biomarker Test - Autoimmune Diseases Product Overview
Multi-Biomarker Test - Inflammatory Diseases
Multi-Biomarker Test - Inflammatory Diseases Product Overview
Multi-Biomarker Test - Psoriatic Arthritis
Multi-Biomarker Test - Psoriatic Arthritis Product Overview
Multi-Biomarker Test - Systemic Lupus Erythematosus
Multi-Biomarker Test - Systemic Lupus Erythematosus Product Overview
myChoice Diabetes
myChoice Diabetes Product Overview
myChoice HRD (PARP) - Niraparib
myChoice HRD (PARP) - Niraparib Product Overview
myChoice HRD (PARP) - Niraparib Clinical Trial
myChoice HRD (PARP) - Talazoparib
myChoice HRD (PARP) - Talazoparib Product Overview
myChoice HRD (PARP) - Talazoparib Clinical Trial
myChoice HRD (Platinum)
myChoice HRD (Platinum) Product Overview
myChoice HRD (Platinum) Clinical Trial
myPath BiPolar
myPath BiPolar Product Overview
myPath Endometriosis
myPath Endometriosis Product Overview
myPath Pancreatic Cancer
myPath Pancreatic Cancer Product Overview
myPath Prostate Cancer
myPath Prostate Cancer Product Overview
myPath Psoriatic Arthritis
myPath Psoriatic Arthritis Product Overview
myPlan Renal Cancer
myPlan Renal Cancer Product Overview
myRisk Schizophrenia
myRisk Schizophrenia Product Overview
Prognostic Test - Bladder Cancer
Prognostic Test - Bladder Cancer Product Overview
SanoPredict
SanoPredict Product Overview
Tumor BRACAnalysis CDx - Veliparib
Tumor BRACAnalysis CDx - Veliparib Product Overview
VeriPsych Test - Bipolar Disorder
VeriPsych Test - Bipolar Disorder Product Overview
Myriad Genetics Inc - Key Competitors
Myriad Genetics Inc - Key Employees
Myriad Genetics Inc - Key Employee Biographies
Myriad Genetics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Myriad Genetics Inc, Recent Developments
Jul 18, 2018: Myriad announces coverage decision by Kroger Prescription Plans for Vectra DA
Jun 28, 2018: BRACAnalysis CDx Identifies Patients Who Respond to Lynparza in SOLO-1 Study
Jun 21, 2018: Top-Five National Payer Issues Positive Coverage Decision for Myriad’s Prolaris Test for Prostate Cancer
Jun 18, 2018: Myriad’s BRACAnalysis CDx Supplementary PMA Accepted by FDA for Review as a Companion Diagnostic for Talazoparib in Metastatic Breast Cancer
Jun 06, 2018: Crescendo Bioscience Announces Four Studies with Vectra DA Will Be Featured at the 2018 European League Against Rheumatism Annual Meeting
Jun 01, 2018: Myriad Genetics Presents Second Pivotal Validation Study for riskScore Test at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
May 31, 2018: GeneSight Guided Treatment Significantly Improves Outcomes for Patients with Major Depression Treated in the Primary Care Setting
May 23, 2018: Myriad Announces Seven New Payer Coverage Decisions for Prolaris
May 15, 2018: Myriad Genetics to Present Eight Studies at the 2018 American Society of Clinical Oncology Annual Meeting
May 15, 2018: New Publication on Counsyl’s Foresight Carrier Screen Validates the Highly Accurate Detection of Couples At-Risk for Children With Serious Disease
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Myriad Genetics Inc Pipeline Products and Ongoing Clinical Trials Overview
Myriad Genetics Inc Pipeline Products by Equipment Type
Myriad Genetics Inc Pipeline Products by Indication
Myriad Genetics Inc Ongoing Clinical Trials by Trial Status
Myriad Genetics Inc, Key Facts
Myriad Genetics Inc, Major Products and Services
Myriad Genetics Inc Number of Pipeline Products by Development Stage
Myriad Genetics Inc Pipeline Products Summary by Development Stage
Myriad Genetics Inc Ongoing Clinical Trials by Trial Status
Myriad Genetics Inc Ongoing Clinical Trials Summary
BRACAnalysis CDx - Talazoparib - Product Status
BRACAnalysis CDx - Talazoparib - Product Description
ChemoPredict Test - Product Status
ChemoPredict Test - Product Description
Diagnostic Assay - Lung Cancer - Product Status
Diagnostic Assay - Lung Cancer - Product Description
Diagnostic Assay - HER2+/TNBC-Breast Cancer - Product Status
Diagnostic Assay - HER2+/TNBC-Breast Cancer - Product Description
Diagnostic Assay - Juvenile Idiopathic Rheumatoid Arthritis - Product Status
Diagnostic Assay - Juvenile Idiopathic Rheumatoid Arthritis - Product Description
Diagnostic Assay - Melanoma - Product Status
Diagnostic Assay - Melanoma - Product Description
Diagnostic Assay - Prostate Cancer - Product Status
Diagnostic Assay - Prostate Cancer - Product Description
Diagnostic Test - Alzheimer's Disease - Product Status
Diagnostic Test - Alzheimer's Disease - Product Description
Diagnostic Test - Colon Cancer - Product Status
Diagnostic Test - Colon Cancer - Product Description
Diagnostic Test - Kidney Damage - Product Status
Diagnostic Test - Kidney Damage - Product Description
GeneSight Test - MDD - Product Status
GeneSight Test - MDD - Product Description
GeneSight Test - MDD - PRIME Care (Precision Medicine In Mental Health Care)
Genetic Risk Score Test - Product Status
Genetic Risk Score Test - Product Description
Genetic Risk Score Test - Clinical Trial to Examine Use of Predictive Genetic Tests for Cancer Risks Assessment
HRD Companion Diagnostic Test - Breast Cancer - Product Status
HRD Companion Diagnostic Test - Breast Cancer - Product Description
Kidney Transplant Rejection Test - Product Status
Kidney Transplant Rejection Test - Product Description
Multi-Biomarker Test - Ankylosing Spondylitis - Product Status
Multi-Biomarker Test - Ankylosing Spondylitis - Product Description
Multi-Biomarker Test - Autoimmune Diseases - Product Status
Multi-Biomarker Test - Autoimmune Diseases - Product Description
Multi-Biomarker Test - Inflammatory Diseases - Product Status
Multi-Biomarker Test - Inflammatory Diseases - Product Description
Multi-Biomarker Test - Psoriatic Arthritis - Product Status
Multi-Biomarker Test - Psoriatic Arthritis - Product Description
Multi-Biomarker Test - Systemic Lupus Erythematosus - Product Status
Multi-Biomarker Test - Systemic Lupus Erythematosus - Product Description
myChoice Diabetes - Product Status
myChoice Diabetes - Product Description
myChoice HRD (PARP) - Niraparib - Product Status
myChoice HRD (PARP) - Niraparib - Product Description
myChoice HRD (PARP) - Niraparib - A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Niraparib Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
myChoice HRD (PARP) - Niraparib - A Phase II, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Patients with Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received Three or Four Previous Chemotherapy Regimens
myChoice HRD (PARP) - Niraparib - Phase I of Bevacizumab-Niraparib Combination. AVANOVA2 -A 3-arm, Phase II Randomized Study of Niraparib &/or Niraparib-bevacizumab Combination Against Bevacizumab Alone in HRD Platinum-sensitive Epithelial Ovarian Cancer: AVANOVA1
myChoice HRD (PARP) - Talazoparib - Product Status
myChoice HRD (PARP) - Talazoparib - Product Description
myChoice HRD (PARP) - Talazoparib - A Phase II Clinical Trial of the PARP Inhibitor Talazoparib in BRCA1 and BRCA2 Wild-type Patients with (i) Advanced Triple-negative Breast Cancer and Homologous Recombination Deficiency, and (ii) Advanced HER2-negative Breast Cancer or Other Solid Tumors with Either a Mutation in Homologous Recombination Pathway Genes
myChoice HRD (Platinum) - Product Status
myChoice HRD (Platinum) - Product Description
myChoice HRD (Platinum) - A Randomized Phase II Study of Preoperative Cisplatin Versus Paclitaxel in Patients with Triple Negative Breast Cancer: Evaluating the Homologous Recombination Deficiency (HRD) Biomarker
myPath BiPolar - Product Status
myPath BiPolar - Product Description
myPath Endometriosis - Product Status
myPath Endometriosis - Product Description
myPath Pancreatic Cancer - Product Status
myPath Pancreatic Cancer - Product Description
myPath Prostate Cancer - Product Status
myPath Prostate Cancer - Product Description
myPath Psoriatic Arthritis - Product Status
myPath Psoriatic Arthritis - Product Description
myPlan Renal Cancer - Product Status
myPlan Renal Cancer - Product Description
myRisk Schizophrenia - Product Status
myRisk Schizophrenia - Product Description
Prognostic Test - Bladder Cancer - Product Status
Prognostic Test - Bladder Cancer - Product Description
SanoPredict - Product Status
SanoPredict - Product Description
Tumor BRACAnalysis CDx - Veliparib - Product Status
Tumor BRACAnalysis CDx - Veliparib - Product Description
VeriPsych Test - Bipolar Disorder - Product Status
VeriPsych Test - Bipolar Disorder - Product Description
Myriad Genetics Inc, Key Employees
Myriad Genetics Inc, Key Employee Biographies
Myriad Genetics Inc, Subsidiaries
Glossary
List of Figures
Myriad Genetics Inc Pipeline Products by Equipment Type
Myriad Genetics Inc Pipeline Products by Development Stage
Myriad Genetics Inc Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report